Use of corticosteroids for remission induction therapy in patients with new-onset ulcerative colitis in real-world settings
Background: Corticosteroids may be temporarily effective for ulcerative colitis (UC), but long-term use increases the risk of adverse drug reactions. Objective: The goal of the study was to examine steroid use in remission induction therapy after diagnosis of UC. Study Design: A retrospective observ...
Saved in:
| Main Authors: | Motohiro Okayasu, Haruhiko Ogata, Yuji Yoshiyama |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2019-01-01
|
| Series: | Journal of Market Access & Health Policy |
| Subjects: | |
| Online Access: | http://dx.doi.org/10.1080/20016689.2019.1565889 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Filgotinib induction-study baseline characteristics of patients with ulcerative colitis who achieve sustained corticosteroid-free remission: analysis of the phase 2b/3 SELECTION study
by: Taku Kobayashi, et al.
Published: (2025-01-01) -
The use of corticosteroids in the treatment of ulcerative colitis: A brief overview
by: Radlović Aleksandar, et al.
Published: (2025-01-01) -
Predictive accuracy of fecal calprotectin for histologic remission in ulcerative colitis
by: Arshdeep Singh, et al.
Published: (2025-04-01) -
EVALUATION OF HISTOLOGICAL PARAMETERS IN PATIENTS WITH CLINICAL REMISSION OF ULCERATIVE COLITIS
by: O. B. Shchukina, et al.
Published: (2014-11-01) -
Using Dose-Effect Relationship for Optimising Systemic Corticosteroid Dosage in Treatment of Inflammatory Bowel Diseases
by: O. P. Alekseeva, et al.
Published: (2020-12-01)